인쇄하기
취소

KFDA cautions adverse reactions in ticlopidine HCl therapy

Published: 2002-07-30 06:58:00
Updated: 2002-07-30 06:58:00
The Korea Food and Drug Administration (KFDA) said it recommended the local doctors to conduct the regular hematology and liver functions tests in patients receiving ticlopidine HCl preparations (41 pharmaceutical firms, 61 licensed items), in line with the recent Japanese health ministrys measures that all manufacturers of ticlopidine HCl are officially required to additionally describe more r...

Fees

- Email service daily and homepage access.
  1. $300 per month.
  2. 5 Email holders per each company.
  3. Anual contract base.
Copyright Yakup.com All rights reserved.
약업닷컴의 모든 컨텐츠는 저작권법의 보호를 받습니다. 무단 전재⋅복사⋅배포 등을 금합니다.